Onboarding Patients on JAK Inhibitors for Atopic Dermatitis - Episode 1
Oral JAK Inhibitors in Atopic Dermatitis
Published on:
Ruth Ann Vleugels, MD, MPH, MBA, provides an overview of oral JAK inhibitors approved for the treatment of atopic dermatitis and describes what makes them an attractive therapeutic option.
Video content above is prompted by the following questions:
- Please review the oral JAK inhibitors that have been approved for atopic dermatitis (AD).
- Which patients are they approved for?
- What makes JAK inhibitors an attractive option for AD treatment?
- How are oral JAK inhibitors utilized in other diseases?
